If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

Share Price Information for Ferrexpo (FXPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.70
Bid: 48.50
Ask: 48.85
Change: -1.25 (-2.50%)
Spread: 0.35 (0.722%)
Open: 50.70
High: 50.70
Low: 48.50
Prev. Close: 49.95
FXPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of the placing in Ferrexpo plc

28 Oct 2016 07:00

RNS Number : 7145N
J.P. Morgan Securities PLC.
28 October 2016
 

Not for publication, distribution or release directly or indirectly, in whole or in part, in or into the United States, Australia, Canada or Japan or in any other jurisdiction in which offers or sales would be prohibited by applicable law.

This announcement is not an offer to sell or a solicitation to buy securities in any jurisdiction, including the United States, Australia, Canada or Japan. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

Result of secondary placing of shares in Ferrexpo plc

Wigmore Street Investments No. 3 Limited (the "Seller"), announces that it has sold an aggregate of 63 million ordinary shares of Ferrexpo plc (the "Company"), representing approximately 10.7 per cent. of the Company's existing issued ordinary share capital, at a price of 110 pence per share (the "Placing") raising aggregate gross proceeds of approximately £69 million.

Following settlement of the Placing, which is expected to take place on 1 November 2016, the Seller will hold approximately 13.2 per cent. of the Company's existing issued share capital. The Seller has agreed that it will not, for a period of 90 days following the completion of the Placing, offer, sell or otherwise transfer any shares from its remaining shareholding in the Company.

The Seller is a subsidiary of CERCL Holdings Limited, a joint venture between the BXR Group and Mr. Zdenek Bakala and his family interests.

Enquiries:

J.P. Morgan Cazenove +44 207 742 4000

Nicholas Hall

Charlie Walker

 

The distribution of this announcement and the offer and sale of the Placing Shares in certain jurisdictions may be restricted by law. The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by the Sellers, J.P. Morgan Cazenove or any of their respective affiliates that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and dependencies, any State of the United States and the District of Columbia), Australia, Canada or Japan or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression 'Prospectus Directive' means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive"' means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

In connection with the Offering, J.P. Morgan Cazenove and any of its affiliates acting as an investor for its own account may take up a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. J.P. Morgan Cazenove does not intend to disclose the extent of any such investment or transactions other than in accordance with any legal or regulatory obligation to do so.

J.P. Morgan Cazenove, which is authorised and regulated in the United Kingdom by the Prudential Regulation Authority and regulated by the Financial Conduct Authority, is acting on behalf of the Sellers and no one else in connection with the Offering and will not be responsible to any other person for providing the protections afforded to any of their clients or for providing advice in relation to any offering of the Placing Shares. J.P. Morgan Cazenove will not regard any other person as their client in relation to the Offering. J.P. Morgan Securities plc conducts its UK investment banking activities as J.P. Morgan Cazenove.

This document includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. Any forward-looking statements are subject to risks relating to future events and assumptions relating to the Company's business, in particular from changes in political conditions, economic conditions, evolving business strategy, or the retail industry. No assurances can be given that the forward-looking statements in this document will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual results or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIGUBDGXSDBGLI
Date   Source Headline
7th May 20247:00 amRNSUpdates regarding Ukrainian subsidiary
29th Apr 202411:49 amRNSNotice of Annual General Meeting and 2023 ARA
23rd Apr 20247:00 amRNSProduction Report for 1Q 2024
18th Apr 20247:00 amRNSFull Year Financial Results for 2023
8th Apr 202411:26 amRNSDirector Declaration
26th Mar 20247:00 amRNSUkrainian Subsidiary Corporate Rights Restrictions
25th Mar 20245:23 pmRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSUpdate regarding Ukrainian subsidiary
22nd Mar 20247:00 amRNSTR-1: Notification of major holdings
19th Mar 20245:02 pmRNSTR-1: Notification of major holdings
12th Mar 20245:35 pmRNSUpdates on FY23 Results & Ukrainian Subsidiary
11th Mar 20247:00 amRNSUpdate regarding Ukrainian subsidiary
23rd Feb 20245:00 pmRNSSecond Year Anniversary Letter
20th Feb 202410:58 amRNSUpdate on Interim Dividend
29th Jan 20247:00 amRNSCourt confirms claim against Ukrainian subsidiary
18th Jan 20247:00 amRNSInterim Dividend Announcement
11th Jan 20247:00 amRNSProduction Report for 4Q 2023
28th Dec 20234:30 pmRNSEnd of Year Letter
15th Dec 20234:33 pmRNSPublication of Responsible Business Report
2nd Nov 20233:23 pmRNSInvestigations on use of waste product update
31st Oct 20235:00 pmRNSTR-1: Notification of major holdings
26th Oct 20234:26 pmRNSTR-1: Notification of major holdings
23rd Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
5th Oct 20237:00 amRNSProduction Report for 3Q 2023
21st Sep 20237:00 amRNSRestrictions on Corporate Rights in 2 Subsidiaries
16th Aug 20235:36 pmRNSTR-1: Notification of major holdings
2nd Aug 20237:00 amRNSInterim Results for six months ended 30 June 2023
21st Jul 20237:00 amRNSNotice of Interim Results
17th Jul 202312:25 pmRNSTR-1: Notification of major holdings
6th Jul 20237:00 amRNSProduction Report for 2Q 2023
29th Jun 20237:00 amRNSReport on Payments to Governments for CY2022
14th Jun 202311:01 amRNSTR-1: Notification of major holdings
25th May 20231:35 pmRNSResults of Annual General Meeting
18th May 20233:29 pmRNSTR-1: Notification of major holdings
17th May 20233:21 pmRNSResponse to Media Reports
2nd May 20237:00 amRNSManagement and Board Changes
20th Apr 20239:35 amRNSDirector Declaration – External Appointment
20th Apr 20237:00 amRNSSupreme Court Ruling Dismisses Claim Against FXPO
14th Apr 202311:09 amRNSNotice of Annual General Meeting and 2022 ARA
12th Apr 20232:27 pmRNSTotal Voting Rights
6th Apr 20237:00 amRNSProduction Report for 1Q 2023
29th Mar 202311:45 amRNSDirector/PDMR Shareholding
23rd Mar 20239:30 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFull Year Financial Results for 2022
10th Mar 20237:00 amRNSTransfer of Treasury Shares & Total Voting Rights
7th Mar 20234:17 pmRNSResponse to Media Report
2nd Mar 20234:53 pmRNSTR-1: Notification of major holdings
1st Mar 20237:00 amRNSNotice of Full Year Results
7th Feb 20237:00 amRNSUpdate Regarding Subsidiary’s Accounts in Ukraine
11th Jan 20237:00 amRNSProduction Report and Trading Update for 4Q 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.